lenvatinib - CISMeF

Preferred Label : lenvatinib;

MeSH note : a protein kinase inhibitor; structure in first source;

CISMeF synonym : E 7080; E7080 cpd;

MeSH synonym : 4-(3-chloro-4-(N'-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide; 4-(3-chloro-4-((cyclopropylaminocarbonyl)amino)phenoxy)-7-methoxy-6-quinolinecarboxamide;

MeSH hyponym : E-7080; E7080 mesylate; N-(4-((6-carbamoyl-7-methoxyquinolin-4-yl)oxy)-2-chlorophenyl)-N'-cyclopropylurea monomethanesulfonate; lenvatinib mesilate; lenvatinib methanesulfonate; Lenvima; E-7080 mesylate; ER-203492-00; E7080; 4-(3-chloro-4-(((cyclopropylamino)carbonyl)amino)phenoxy)-7-hydroxy-6-quinolinecarboxamide;

Related MeSH term : E7080 mesylate;

MeSH Related Number : 269N24780P; 3J78384F61;

Is substance : O;

UNII : EE083865G2;

InChIKey : WOSKHXYHFSIKNG-UHFFFAOYSA-N;

Details

Origin ID

C531958;

UMLS CUI

C2986924;

ATC code(s)
- lenvatinib [ATC Code]
Automatic exact mappings (from CISMeF team)
- Lenvatinib Mesylate [NCIt concept]
CISMeF manual mappings
- Lenvatinib (substance) [SNOMED CT concept]
- lenvatinib [Substance BNPC]
Currated CISMeF NLP mapping
- Lenvatinib [NCIt concept]
MeSH term(s) associated for indexing
- phenylurea compounds [MeSH Descriptor]
- quinolines [MeSH Descriptor]
Pharmacological action(s)
- antineoplastic agents [MeSH Descriptor]
- protein kinase inhibitors [MeSH Descriptor]
Record concept(s)
- E 7080 [MeSH concept]
- E-7080 mesylate [MeSH concept]
- Lenvima [MeSH concept]
- lenvatinib [MeSH concept]
- lenvatinib mesylate [MeSH concept]
- lenvatinib metabolite M2 [MeSH concept]
See also inter- (CISMeF)
- Product containing lenvatinib (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Lenvatinib [NCIt concept]
- Lenvatinib (substance) [SNOMED CT concept]
- Product containing lenvatinib (medicinal product) [SNOMED CT concept]
- lenvatinib [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients